BostonGene, developer of the leading AI foundation model for tumor and immune biology, today announced that Nathan Fowler, MD, Chief Medical Officer at BostonGene will deliver multiple presentations ...
H2Ocean proudly participated in the 4th International Conference on Cancer Health Disparities (ICCHD) & 9th Annual ...
Barclays 28th Annual Global Healthcare Conference March 10, 2026 11:30 AM EDTCompany ParticipantsRyan Cohlhepp - ...
Omics-driven insights into tumor microenvironment determinants of immunotherapy response in melanoma
Immunotherapy has revolutionized cancer treatment, yet response rates remain highly variable across tumor types and individual patients. Increasing evidence ...
Colorectal cancer (CRC) remains one of the most prevalent malignancies and a leading cause of cancer-related mortality worldwide. Beyond tumor-intrinsic ...
A recent integrative analysis of single-cell sequencing and single-cell spatial mapping of lymph node metastasis in breast cancer reveals novel mechanisms of the metabolic-immune interaction that ...
Researchers at the Cancer Research Institute and the Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, have ...
Leerink Partners Global Healthcare Conference Format: Fireside Chat Date: Wednesday, March 11, 2026 Time: 8:00 AM ET Webcast ...
News-Medical.Net on MSN
Study reveals cellular and metabolic landscape of lymph node metastasis in breast cancer
A recent integrative analysis of single-cell sequencing and single-cell spatial mapping of lymph node metastasis in breast ...
News-Medical.Net on MSN
Distinct spatial tumor–immune ecosystems predict lung cancer treatment response
Researchers at Moffitt Cancer Center have identified distinct spatial tumor–immune ecosystems that predict whether patients with advanced non–small cell lung cancer will benefit from immunotherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results